Technical standards in allergen exposure chambers worldwide – an EAACI Task Force Report

Oliver Pfaar(Heidelberg University), Petra Zieglmayer(Karl Landsteiner University of Health Sciences), Anne Marie Salapatek(Inflamax Research (Canada)), Nathalie Domis, Yoshitaka Okamoto(Chiba University), Karl‐Christian Bergmann(Charité - Universitätsmedizin Berlin), Alina Gherasim, Anne K. Ellis(Queen's University), Hendrik Nolte(University of Cologne), Jens M. Hohlfeld(Medizinische Hochschule Hannover), С. Бонини(University of Campania "Luigi Vanvitelli"), Suzanne Kelly(Robarts Clinical Trials), Ronald L. Rabin(Center for Biologics Evaluation and Research), Laura Haya(Robarts Clinical Trials), Philippe Devillier(Inserm), Ludger Klimek(Zentrum für Rhinologie und Allergologie), Robert L. Jacobs(Biogen (United States)), Stephen R. Durham(Imperial College London), Cynthia Rather(Biogen (United States)), Marek Jutel(Wroclaw Medical University), Pieter‐Jan de Kam(Allergy Therapeutics (United Kingdom)), Tomohisa Iinuma(Chiba University), Alkis Togias(National Institute of Allergy and Infectious Diseases), Patrick Lemell(Vienna Challenge Chamber), Enrico Compalati, Mark Larché(St. Joseph’s Healthcare Hamilton), Torben Sigsgaard(Institute of Public Health), F. de Blay(Hôpital Civil, Strasbourg), Piyush M. Patel(Sun Pharma (India)), Friedrich Horak(Allergiezentrum Wien West), René Zieglmayer(Vienna Challenge Chamber), Christoph Willers, William H. Yang(Ottawa Allergy Research Corporation), Henrik H. Jacobi(ALK-Abelló (Denmark)), Angelika Sager(LETI Pharma (Germany)), Torsten Zuberbier(Humboldt-Universität zu Berlin), Susanne Kaul(Paul Ehrlich Institut), Vera Mahler(Paul Ehrlich Institut)
Allergy
May 24, 2021
Cited by 39


Related Papers